BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 30577986)

  • 1. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
    Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
    Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
    Walters KM; Waldram JD; Woessner KM; White AA
    Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
    DeGregorio GA; Singer J; Cahill KN; Laidlaw T
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
    Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
    Simon RA; Dazy KM; Waldram JD
    Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
    Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
    Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
    Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
    Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study.
    Sommer DD; Hoffbauer S; Au M; Sowerby LJ; Gupta MK; Nayan S
    Otolaryngol Head Neck Surg; 2015 Jan; 152(1):42-7. PubMed ID: 25344589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AERD Associated Nasal Polyposis: Efficacy of Postoperative Antileukotriene Therapy in Comparison with Aspirin Desensitization. A Retrospective Study.
    San Nicoló M; Habermann N; Havel M
    Int Arch Allergy Immunol; 2020; 181(10):790-798. PubMed ID: 32777782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of aspirin exacerbated respiratory disease patients treated with aspirin desensitization and biologics.
    D'Souza GE; Nwagu U; Barton B; Unsal AA; Rabinowitz MR; Rosen MR; Nyquist GG; Cohn J; Most J; Toskala EM
    Int Forum Allergy Rhinol; 2022 Mar; 12(3):306-309. PubMed ID: 34719120
    [No Abstract]   [Full Text] [Related]  

  • 13. Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study.
    Gudziol V; Michel M; Sonnefeld C; Koschel D; Hummel T
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1487-1493. PubMed ID: 27830335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.
    Stevens WW; Jerschow E; Baptist AP; Borish L; Bosso JV; Buchheit KM; Cahill KN; Campo P; Cho SH; Keswani A; Levy JM; Nanda A; Laidlaw TM; White AA
    J Allergy Clin Immunol; 2021 Mar; 147(3):827-844. PubMed ID: 33307116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Rhinosinusitis Outcomes of Patients With Aspirin-Exacerbated Respiratory Disease Treated With Budesonide Irrigations: A Case Series.
    Talat R; Gengler I; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
    Ann Otol Rhinol Laryngol; 2022 Oct; 131(10):1130-1136. PubMed ID: 34775833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
    Świerczyńska-Krępa M; Sanak M; Bochenek G; Stręk P; Ćmiel A; Gielicz A; Plutecka H; Szczeklik A; Niżankowska-Mogilnicka E
    J Allergy Clin Immunol; 2014 Oct; 134(4):883-90. PubMed ID: 24767875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin desensitization therapy in aspirin-exacerbated respiratory disease: a systematic review.
    Larivée N; Chin CJ
    Int Forum Allergy Rhinol; 2020 Apr; 10(4):450-464. PubMed ID: 31951112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease.
    Adappa ND; Ranasinghe VJ; Trope M; Brooks SG; Glicksman JT; Parasher AK; Palmer JN; Bosso JV
    Int Forum Allergy Rhinol; 2018 Jan; 8(1):49-53. PubMed ID: 29105347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
    O'Brien EK; Jerschow E; Divekar RD
    Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biologic therapy in patients with severe NSAID-exacerbated respiratory disease and previous aspirin desensitization : Results of a multicentric study].
    Staufenberg AR; Frankenberger HK; Förster-Ruhrmann U; Spahn FC; Klimek L; Fruth K; Stihl C; Matthias C; Gröger M; Hagemann J
    HNO; 2024 Jul; 72(7):473-483. PubMed ID: 38466409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.